Blog Posts

House GOP Rejects Democrats’ Push to Link 340B Transparency and Contract Pharmacy

E&C 340B
House E&C Democrat Scott Peters (Calif.) spoke in favor of, and fellow Democrat Debbie Dingell (Mich.) spoke against, a Republican bill to impose reporting requirements on 340B DSH hospitals.

Congressional GOP backers of federal reporting requirements for 340B hospitals yesterday rejected Democratic arguments that fairness dictates that those requirements be paired with 340B contract pharmacy requirements for drug manufacturers.

U.S. House Energy & Commerce Committee Republicans, joined

Read More »

340B Grantees Need More Scrutiny as Drug Margins Rise, Gilead-funded Study Says

Gilead BGR study
340B contract pharmacy arrangements rose 252% for grantee covered entities between 2017 to 2022 compared to 194% for hospitals, a new drug company-funded study found.

Health centers and other federal grantees’ 340B savings and how they use them need more scrutiny, as these covered entities account for a large chunk of total 340B drug sales and their margins are keeping pace with those

Read More »

3 Tips for Navigating the Current 340B Environment


Many people have been losing sleep thinking about how they should move forward in the current 340B environment. Over the last 18 months, it has felt like an external force is around every corner, pushing or pulling covered entities into new areas of discomfort.

During these turbulent times, it can help to find partners who

Read More »

340B Advocacy Group CV340B Plans March on Capitol Hill July 12

Community Voices for 340B (CV340B) on July 12 is holding its second annual Defend 340B March on Capitol Hill. The first was in August 2022.

340B grassroots group Community Voices for 340B (CV340B) has announced plans to hold its second annual Defend 340B March on Capitol Hill July 12.

A primary goal of the event is to raise awareness among lawmakers about

Read More »

Breaking News

House E&C Committee Passes Two Bills That Would Create 340B Entity Reporting Requirements

Energy & Commerce Committee
The House E&C Committee passed a bill to impose reporting requirements on 340B DSH hospitals and potentially other entities. The committee passed another bill that could expose all types of 340B covered entities to separate reporting requirements.

The House Energy & Commerce Committee passed two bills today to impose 340B program reporting requirements on hospitals and other health care providers.

They were among 19 health care, telecommunications, and energy bills that the committee marked

Read More »

House E&C Committee to Vote Tomorrow on Bills That Would Bring Big Changes to 340B

House E&C Committee
The House E&C Committee tomorrow will markup two bills that 340B providers are watching very closely.

340B provider groups won some concessions on controversial Medicaid managed care drug billing language that the full U.S. House Energy & Commerce Committee is marking up tomorrow, lobbyists say. Efforts to get more changes continue.

The committee

Read More »

Health Centers’ Antitrust Case Over 340B Contract Pharmacy Limits Will be Argued July 20

Federal District Court Rochester
There will be a federal district court hearing July 20 in Rochester, N.Y., in two health centers' 340B-related antitrust suit against insulin and diabetes drug makers.

A once-dead lawsuit that accuses drug makers of colluding to deny 340B pricing on insulin and diabetes drugs shipped to contract pharmacies is going to be heard July 20 in federal district court in Rochester, N.Y.

Chief Judge

Read More »

Tips for Specialty Pharmacy Success


The Origin and Evolution of Specialty Pharmacy

Commencing in the early 1970s, specialty pharmacy was originally intended for patients requiring unique therapies for various conditions. Initially this included mainly infusions for hemophilia, cancer, or malnutrition[i]. Most of these offerings came with high costs (many of which can now be offset by copay

Read More »

Providers Added Immediately to 340B Under COVID-19 Flexibility Are Not Losing their Eligibility, HRSA Confirms

HRSA OPA homepage
HRSA confirmed that providers granted immediate 340B enrollment under a COVID-19 flexibility are not losing their 340B eligibility and will not need to re-enroll. HRSA recently posted a notice about those enrollments on the OPA homepage.

Federal 340B program officials confirmed last week that providers granted immediate 340B enrollment under a COVID-19 public health emergency flexibility are not losing their 340B eligibility and will not need to re-enroll now that the PHE is over.

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


*Sign up for news summaries and alerts from 340B Report

Site Footer